ExodusPoint Capital Management, LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1736225 NEW YORK, NY

Position in TBPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$365,041

+$111,099 QoQ

Shares Held

21,473

-24.5% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#92

of 179 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. TBPH ranks #76 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	249,259	$21,234,374
2	BBIO	BridgeBio Pharma, Inc.	224,927	$16,752,562
3	ORKA	Oruka Therapeutics, Inc.	148,212	$14,105,336
4	VKTX	Viking Therapeutics, Inc.	361,126	$14,087,525
5	JAZZ	Jazz Pharmaceuticals plc	53,201	$12,819,844
6	NAMS	NewAmsterdam Pharma Co N.V.	304,334	$10,313,879
7	TGTX	Tg Therapeutics, Inc.	164,513	$9,038,344
8	DNLI	Denali Therapeutics Inc.	336,567	$8,656,503

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$365,041	21,473	-24.5%	Shares	Sole	2026-08-14
2025-03-31	$253,942	28,437	-25.2%	Shares	Sole	2025-05-14
2024-09-30	$306,425	38,018	-53.0%	Shares	Sole	2024-11-12
2024-06-30	$686,498	80,955	+0.2%	Shares	Sole	2024-08-13
2024-03-31	$724,372	80,755	-31.2%	Shares	Sole	2024-05-14
2023-09-30	$1,012,454	117,318	+13.2%	Shares	Sole	2023-11-13
2023-06-30	$1,073,098	103,681	+92.5%	Shares	Other	2023-08-11
2022-03-31	$514,806	53,850	+264.1%	Shares	Other	2022-05-13
2021-09-30	$109,453	14,791	-83.7%	Shares	Other	2021-11-15
2021-06-30	$1,319,345	90,864	+391.9%	Shares	Other	2021-08-16
2020-09-30	$273,108	18,472	-41.2%	Shares	Sole	2020-11-16
2020-06-30	$659,190	31,405	—	Shares	Other	2020-08-14
No filing history on record for this holder in this stock.